CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies

S. Nishino, T. Kanbayashi, N. Fujiki, M. Uchino, B. Ripley, M. Watanabe, G. J. Lammers, H. Ishiguro, S. Shoji, Y. Nishida, S. Overeem, I. Toyoshima, Y. Yoshida, T. Shimizu, Shahrad Taheri, E. Mignot

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

CSF hypocretin-1 was measured in 28 Guillain-Barré syndrome (GBS), 12 Miller-Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (<100 pg/mL). Hypocretin-1 levels were moderately reduced in an additional 11 GBS, 5 Miller-Fisher syndrome, and 1 CIDP subject. Low levels in GBS occurred early in the disease and were associated with upper CNS level abnormalities.

Original languageEnglish
Pages (from-to)823-825
Number of pages3
JournalNeurology
Volume61
Issue number6
Publication statusPublished - 23 Sep 2003
Externally publishedYes

Fingerprint

Miller Fisher Syndrome
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Macrophage Colony-Stimulating Factor
Orexins

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Nishino, S., Kanbayashi, T., Fujiki, N., Uchino, M., Ripley, B., Watanabe, M., ... Mignot, E. (2003). CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology, 61(6), 823-825.

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. / Nishino, S.; Kanbayashi, T.; Fujiki, N.; Uchino, M.; Ripley, B.; Watanabe, M.; Lammers, G. J.; Ishiguro, H.; Shoji, S.; Nishida, Y.; Overeem, S.; Toyoshima, I.; Yoshida, Y.; Shimizu, T.; Taheri, Shahrad; Mignot, E.

In: Neurology, Vol. 61, No. 6, 23.09.2003, p. 823-825.

Research output: Contribution to journalArticle

Nishino, S, Kanbayashi, T, Fujiki, N, Uchino, M, Ripley, B, Watanabe, M, Lammers, GJ, Ishiguro, H, Shoji, S, Nishida, Y, Overeem, S, Toyoshima, I, Yoshida, Y, Shimizu, T, Taheri, S & Mignot, E 2003, 'CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies', Neurology, vol. 61, no. 6, pp. 823-825.
Nishino S, Kanbayashi T, Fujiki N, Uchino M, Ripley B, Watanabe M et al. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology. 2003 Sep 23;61(6):823-825.
Nishino, S. ; Kanbayashi, T. ; Fujiki, N. ; Uchino, M. ; Ripley, B. ; Watanabe, M. ; Lammers, G. J. ; Ishiguro, H. ; Shoji, S. ; Nishida, Y. ; Overeem, S. ; Toyoshima, I. ; Yoshida, Y. ; Shimizu, T. ; Taheri, Shahrad ; Mignot, E. / CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. In: Neurology. 2003 ; Vol. 61, No. 6. pp. 823-825.
@article{b49f811b4aeb4b23b93f313bd7167b74,
title = "CSF hypocretin levels in Guillain-Barr{\'e} syndrome and other inflammatory neuropathies",
abstract = "CSF hypocretin-1 was measured in 28 Guillain-Barr{\'e} syndrome (GBS), 12 Miller-Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (<100 pg/mL). Hypocretin-1 levels were moderately reduced in an additional 11 GBS, 5 Miller-Fisher syndrome, and 1 CIDP subject. Low levels in GBS occurred early in the disease and were associated with upper CNS level abnormalities.",
author = "S. Nishino and T. Kanbayashi and N. Fujiki and M. Uchino and B. Ripley and M. Watanabe and Lammers, {G. J.} and H. Ishiguro and S. Shoji and Y. Nishida and S. Overeem and I. Toyoshima and Y. Yoshida and T. Shimizu and Shahrad Taheri and E. Mignot",
year = "2003",
month = "9",
day = "23",
language = "English",
volume = "61",
pages = "823--825",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies

AU - Nishino, S.

AU - Kanbayashi, T.

AU - Fujiki, N.

AU - Uchino, M.

AU - Ripley, B.

AU - Watanabe, M.

AU - Lammers, G. J.

AU - Ishiguro, H.

AU - Shoji, S.

AU - Nishida, Y.

AU - Overeem, S.

AU - Toyoshima, I.

AU - Yoshida, Y.

AU - Shimizu, T.

AU - Taheri, Shahrad

AU - Mignot, E.

PY - 2003/9/23

Y1 - 2003/9/23

N2 - CSF hypocretin-1 was measured in 28 Guillain-Barré syndrome (GBS), 12 Miller-Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (<100 pg/mL). Hypocretin-1 levels were moderately reduced in an additional 11 GBS, 5 Miller-Fisher syndrome, and 1 CIDP subject. Low levels in GBS occurred early in the disease and were associated with upper CNS level abnormalities.

AB - CSF hypocretin-1 was measured in 28 Guillain-Barré syndrome (GBS), 12 Miller-Fisher syndrome, 12 chronic inflammatory demyelinating polyneuropathy (CIDP), and 48 control subjects. Seven GBS subjects had undetectably low hypocretin-1 levels (<100 pg/mL). Hypocretin-1 levels were moderately reduced in an additional 11 GBS, 5 Miller-Fisher syndrome, and 1 CIDP subject. Low levels in GBS occurred early in the disease and were associated with upper CNS level abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=10744229433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744229433&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 823

EP - 825

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -